-
SCPS Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Scopus BioPharma (SCPS)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 362.10 k | 362.10 k | 362.10 k | 362.10 k | 362.10 k | 362.10 k |
Cash burn (monthly) | 346.46 k | 66.20 k | 976.29 k | 778.58 k | 336.41 k | 253.55 k |
Cash used (since last report) | 6.17 mm | 1.18 mm | 17.39 mm | 13.87 mm | 5.99 mm | 4.52 mm |
Cash remaining | -5.81 mm | -817.29 k | -17.03 mm | -13.51 mm | -5.63 mm | -4.16 mm |
Runway (months of cash) | -16.8 | -12.3 | -17.4 | -17.4 | -16.7 | -16.4 |
13F holders | Current |
---|---|
Total holders | 14 |
Opened positions | 1 |
Closed positions | 6 |
Increased positions | 1 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 6.75 mm |
Total shares | 2.85 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
HCFP/Capital Partners 18B-1 | 1.35 mm | $3.71 mm |
SCPS/Strategic Capital Partners | 1.07 mm | $2.94 mm |
Geode Capital Management | 217.08 k | $52.00 k |
M&R Capital Management | 76.82 k | $18.00 k |
Renaissance Technologies | 61.10 k | $15.00 k |
Tower Research Capital | 26.53 k | $6.00 k |
HRT Financial | 14.35 k | $3.00 k |
First Manhattan | 13.10 k | $3.00 k |
NTRS Northern Trust | 12.52 k | $3.00 k |
JPM JPMorgan Chase & Co. | 5.00 k | $1.00 k |